Skip to main content

Month: June 2022

Vision Hydrogen Acquires Advanced Renewable Fuels Development Project

JERSEY CITY, N.J., June 01, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Vision Hydrogen Corporation (OTCQB: VIHD) (the “Company”) announces that it has acquired a 100% interest in a 14 Ha port development project (the “Project”) for the storage and distribution of low carbon and renewable fuels, including hydrogen carriers such as ammonia, methanol and liquid organics, strategically located in Vlissingen (Flushing) at the mouth of the Westerschelde estuary in the Netherlands. The Project is well positioned to be the first terminal in Europe with a core focus on the storage of low carbon and renewable fuels (including hydrogen carriers from which clean hydrogen may be produced) for European markets and off-takers providing carbon abatement. About Evolution TerminalsEvolution Terminals BV (“EVO”) benefits from a long-lease agreement...

Continue reading

Form 8.3 – [Ideagen plc – 31 05 2022] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IDEAGEN PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDEAGEN PLC AS AN ASSOCIATE OF THE...

Continue reading

Completion of Pharma Intelligence Acquisition by Warburg Pincus From Informa PLC and Appointment of Executive Chair

LONDON and NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) — Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, announces that Warburg Pincus, a leading global growth investor, has completed its acquisition of the business from Informa PLC (LSE:INF.L), the international Academic Markets, B2B Markets and Digital Services Group. The acquisition includes Informa’s full portfolio of specialist brands which includes the Citeline suite of products (Trialtrove, Sitetrove, Pharmaprojects) as well as Biomedtracker, Clinerion, Datamonitor Healthcare, Pink Sheet, Scrip, Skipta, and TrialScope. Pharma Intelligence will now enter its next phase of growth under new ownership. As announced on February 10, Mubadala Investment Company, the Abu Dhabi based...

Continue reading

ReliaQuest to Acquire Digital Shadows

Combined company creates world-class security operations platform to offer customers unmatched visibility and detection to defend against threats TAMPA, Fla., June 01, 2022 (GLOBE NEWSWIRE) — ReliaQuest, a force multiplier of security operations, today announced that it has entered into an agreement to acquire Digital Shadows, a company that delivers threat intelligence for security teams, for $160 million. The acquisition combines ReliaQuest’s ability to extend detection and response across cloud, network, and endpoint environments with Digital Shadows’ digital risk and threat intelligence technology. This gives security operations teams the ability to detect and respond to threats with real-time internal and external visibility. “Combining the internal visibility provided by ReliaQuest with the external threat intelligence...

Continue reading

American Lithium Adds Further Concessions Close to Its Existing Projects in Southern Peru

VANCOUVER, British Columbia, June 01, 2022 (GLOBE NEWSWIRE) — American Lithium Corp. (“American Lithium” or the Company”) (TSX-V: LI, OTCQB: LIACF, Frankfurt: 5LA1) is pleased to confirm that it has signed an agreement to acquire additional concessions in Southern Peru. In addition, it has entered into agreements relating to public relations and marketing activities.   Acquisition of Concessions in Southern Peru The Company, through its Peruvian subsidiary, Macusani Yellowcake S.A.C., has entered into a mining rights transfer agreement (the “Transfer Agreement”) with an arms-length third-party, pursuant to which it will acquire the rights to a series of mining concessions (the “Concessions”) covering approximately 14,243 hectares in Southern Peru. The Concessions are highly prospective and will further broaden the Company’s existing...

Continue reading

IBI Group Enhances Mobility-Based Solutions with Acquisition of HotSpot

– Complementary mobility solution strengthens IBI’s SaaS portfolio and broadens recurring revenue – TORONTO, June 01, 2022 (GLOBE NEWSWIRE) — Global design and technology firm, IBI Group Inc. (TSX: IBG) (“IBI” or the “Company”), announced today that it has acquired mobility solutions provider, HotSpot (the “Acquisition”). Founded in New Brunswick in 2013, HotSpot began addressing parking issues through technology and has since developed into a suite of integrated mobility solutions. Currently, the platform is in use across Canada and parts of the U.S., with more than 80 municipalities, cities and universities, and 460,000 mobile application users leveraging the platform’s mobility solutions. HotSpot’s suite of solutions will complement and bolster IBI’s traffic and transportation practice and its extensive offering...

Continue reading

Forbes Names FTI Consulting #1 Professional Services Firm for New Graduates

WASHINGTON, June 01, 2022 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) was named the leading professional services firm on Forbes magazine’s 2022 list of America’s Best Employers for New Graduates. Among the 300 employers recognized on the list, FTI Consulting was ranked first among professional services firms and #32 overall among companies in the United States. Commenting on the recognition, Holly Paul, Chief Human Resources Officer at FTI Consulting, said, “At FTI Consulting, we encourage young professionals to become the next generation of leaders by honing their skills and developing their expertise in an environment that provides the support and resources necessary to thrive in their careers. Being named the number one professional services firm for new graduates reflects our commitment to attracting, developing and...

Continue reading

Laurentian Bank of Canada reports second quarter 2022 results

The financial information reported herein is based on the condensed interim consolidated (unaudited) information for the three-month period ended April 30, 2022, and has been prepared in accordance with International Financial Reporting standards (IFRS), as issued by the International Accounting Standards Board (IASB). All amounts are denominated in Canadian dollars. The Laurentian Bank of Canada and its entities are collectively referred to as “Laurentian Bank” or the “Bank” and provide deposit, investment, loan, securities, trust and other products or services.MONTREAL, June 01, 2022 (GLOBE NEWSWIRE) — Laurentian Bank of Canada reported net income of $59.5 million and diluted earnings per share of $1.34 for the second quarter of 2022, compared with $53.1 million and $1.15 for the second quarter of 2021. Return on common...

Continue reading

Inozyme Pharma to Present at the 2022 Jefferies Healthcare Conference

BOSTON, June 01, 2022 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization, today announced Axel Bolte, MSc, MBA, the company’s co-founder, president, and chief executive officer, will present at the Jefferies Healthcare Conference. The presentation will take place on Wednesday, June 8, 2022 at 2:30 PM ET. A replay of the presentation can be accessed from the Investor Relations section of Inozyme’s website and will be available for a limited time following the events. About Inozyme Pharma Inozyme Pharma, Inc. (Nasdaq: INZY) is a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft...

Continue reading

Collective Mining Outlines Multiple, High-Grade Vein Systems at Olympus with Assay Results from Channel Sampling of up to 137 g/t Gold and 563 g/t Silver

Figure 1 Plan View of the Guayabales Project Highlighting the Olympus TargetFigure 2 Olympus Target, Measuring 1.4 Kilometres x 0.9 Kilometres and OpenFigure 3: Photos of High-Grade Polymetallic Grab Samples Taken at Olympus Veins of massive sulfides with pyrite, sphalerite, galena and chalcopyrite.TORONTO, June 01, 2022 (GLOBE NEWSWIRE) — Collective Mining Ltd. (TSXV: CNL) (“Collective” or the “Company”) is pleased to announce high-grade gold and silver channel sample assay results from its grassroots generated Olympus target (“Olympus”) located within the Guayabales project (“Guayabales”), Colombia. Olympus is centrally situated within the four-by-four kilometre porphyry cluster where to date, the Company has generated eight drill targets through grassroots prospecting. Four of these targets have been drill tested yielding...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.